TROG0306_2 | R Documentation |
Kaplan-Meier digitized data from TROG0306, figure 2 (PMID 27155740). A reported sample size of 293 for a primary endpoint of OS in prostate cancer.
TROG0306_2
A data frame of 293 observations and 3 variables:
time | event time (in years) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (delayed_adt, immediate_adt) | |
Duchesne GM, Woo HH, Bassett JK, et al. Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial. Lancet Oncol 2016; 17: 727–37.
summary(TROG0306_2)
kmplot(TROG0306_2)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.